Percutaneous transhepatic pancreatic islet cell transplantation in type 1 diabetes mellitus: Radiologic aspects

Radiology

Volumn 229, Issue 1, 2003, Pages 165-170

  Owen, Richard J T ^a   Ryan, Edmond A ^a   O'Kelly, Kevin ^a   Lakey, Jonathan R T ^b   McCarthy, Mairin C ^a   Paty, Breay W ^a   Bigam, David L ^a   Kneteman, Norman M ^b   Korbutt, Gregory S ^b   Rajotte, Ray V ^b   Shapiro, A M James ^b  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Complications; Diabetes mellitus Interventional procedures; Pancreas; Portal vein; Therapeutic embolization; Transplantation

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; DACLIZUMAB; RAPAMYCIN; TACROLIMUS;

ADULT; ARTICLE; BLEEDING; BLOOD PRESSURE MONITORING; BLOOD TRANSFUSION; CANNULATION; CELL ISOLATION; CELL SEPARATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INTERVENTIONAL RADIOLOGY; LIVER HEMATOMA; MALE; PANCREAS ISLET TRANSPLANTATION; PATIENT COMPLIANCE; PATIENT SELECTION; PERCUTANEOUS TRANSHEPATIC PANCREAS ISLET TRANSPLANTATION; PORTAL VEIN; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; TREATMENT INDICATION; VASCULAR ACCESS;

ADULT; CATHETERIZATION, PERIPHERAL; DIABETES MELLITUS, TYPE 1; FEMALE; FLUOROSCOPY; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MIDDLE AGED; PORTAL VEIN; PUNCTURES; RADIOGRAPHY, INTERVENTIONAL; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0141741449     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2291021632     Document Type: Article

References (34)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.
2. Laing SP, Swerdlow AJ, Slater SD, et al. The British Diabetic Association Cohort Study. II. Cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabetes Med 1999; 16:466-471.
3. Laing SP, Swerdlow AJ, Slater SD, et al. The British Diabetic Association Cohort Study. I. All-cause mortality in patients with insulin-treated diabetes mellitus. Diabetes Med 1999; 16:459-465.
4. Sutherland DE, Goetz FC, Najarian JS. Pancreas transplantation. Clin Endocrinol Metab 1982; 11:549-578.
5. Sutherland DE, Gruessner AC, Gruessner RWG. Pancreas transplantation: a review. Transplant Proc 1998; 30:1940-1943.
6. Sutherland DE, Gruessner RW, Dunn DL, et al. Lessons learnt from more than 1,000 pancreas transplants at a single institution. Ann Surg 2001; 233:463-501.
7. Jukema JW, Smets YFC, van der Pill JW, et al. Impact of simultaneous pancreas and kidney transplant on progression of coronary atherosclerosis in patients with end-stage renal failure due to type I diabetes. Diabetes Care 2002; 25:906-911.
8. Kemp CB, Knight MJ, Scharp DW, Lacy PE, Ballinger WF. Transplantation of isolated pancreatic islets into the portal vein of diabetic rats. Nature 1973; 244:447.
9. Steffes MW, Sutherland DE, Mauer SM, Najarian JS, Brown DM. Islet transplantation in diabetic rats receiving corticosteroids. Transplantation 1975; 19:449-455.
10. Walsh TJ, Eggleston JC, Cameron JL. Portal hypertension, hepatic infarction, and liver failure complicating pancreatic islet autotransplantation. Surgery 1982; 91: 485-487.
11. Warnock GL, Kneteman NM, Ryan EA, Seelis REA, Rabinovitch A, Rajotte RV. Normoglycaemia after transplantation of freshly isolated and cryopreserved pancreatic islets in type I diabetes. Diabetologia 1991; 34:55-58.
12. Johnson PR, White SA, Robertson GS, et al. Pancreatic islet autotransplantation combined with total pancreatectomy for the treatment of chronic pancreatitis: the Leicester experience. J Mol Med 1999; 77: 130-132.
13. Weimar B, Rauber K, Brendel MD, Bretzel RG, Rau WS. Percutaneous transhepatic catheterization of the portal vein: a combined CT and fluoroscopy-guided technique. Cardiovasc Intervent Radiol 1999; 22:342-344.
14. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppression regimen. N Engl J Med 2000; 343:230-238.
15. Ryan EA, Lakey JR, Rajotte RV, et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001; 50:710-719.
16. Ryan EA, Lakey JRT, Paty BW, et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002; 51:2148-2157.
17. Casey JJ, Lakey JRT, Ryan EA, et al. Portal venous pressure changes following sequential clinical islet transplantation. Transplantation 2002; 74:913-915.
18. Lakey JR, Warnock GL, Shapiro AM, et al. Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant 1999; 8:285-292.
19. Ricordi C, Lacy PE, Scharp DW. Automated islet isolation from human pancreas. Diabetes 1989; 38(suppl 1):140-142.
20. Linetsky E, Bottino R, Lehmann R, Alejandro R, Inverardi L, Ricordi C. Improved human islet isolation using a new enzyme blend, liberase. Diabetes 1997; 46:1120-1123.
21. Ricordi C, Gray DW, Hering BJ, et al. Islet isolation assessment in man and large animals. Acta Diabetol Lat 1990; 27:185-195.
22. White SA, London NJ, Johnson PR, et al. The risks of total pancreatectomy and splenic islet autotransplantation. Cell Transplant 2000; 9:19-24.
23. Yasunami Y, Lacy PE, Finek EH. A new site for islet transplantation: a peritonealomental pouch. Transplantation 1983; 36:181-182.
24. Carlsson PO, Jansson L, Andersson A, Kallskog O. Capillary blood pressure in syngeneic rat islets transplanted under the renal capsule is similar to that of the transplanted organ. Diabetes 1998; 47:1586-1593.
25. Naji A, Silvers WK, Plotkin SA, Dafoe D, Barker CF. Successful islet transplantation in spontaneous diabetes. Surgery 1979; 86:218-226.
26. Hirshberg B, Montgomery S, Wysoki MG, et al. Pancreatic islet transplantation using the non human primate (rhesus) model predicts that the portal vein in superior to the celiac artery as the islet infusion site. Diabetes 2002; 51:2135-2140.
27. Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg 2001; 88: 165-175.
28. Viamonte M Jr, LePage J, Lunderquist A, et al. Selective catheterization of the portal vein and its tributaries: preliminary report. Radiology 1975; 114:457-460.
29. Van Beers B, Roche A, Cauquil P, Jamart J, Pariente D, Ajavon Y. Transcatheter arterial chemotherapy using doxorubicin, iodized oil and Gelfoam embolization in hepatocellular carcinoma. Acta Radiol 1989; 30:415-418.
30. Owen RJT, Rose JDG. Endovascular treatment of a portal vein tear during TIPSS. Cardiovasc Intervent Radiol 2000; 23:230-232.
31. Luca A, D'Amico G, La Galla R, Midiri M, Morabito A, Pegliaro L. TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology 1999; 212: 411-421.
32. Shapiro AM, Lakey JR, Rajotte RV, et al. Portal vein thrombosis after transplantation of partially purified pancreatic islets in a combined human liver/islet allograft. Transplantation 1995; 59:1060-1063.
33. Schenck E, Nelson JA, Starr FL, Coldwell D. Animal model of portal hypertension with observations regarding the relationship between portal flow and pressure. Invest Radiol 1993; 28:442-445.
34. Kito Y, Nagino M, Nimura Y. Doppler sonography of hepatic arterial blood flow velocity after percutaneous transhepatic portal vein embolization. AJR Am J Roentgenol 2001; 176:909-912.